Showing results (311-320 of 322) with videos related to

Sort By:
Pageof 33
Iscience|August 19, 2022
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptineDespoina Aslanoglou, Suzanne Bertera, Laura Friggeri, et al.
Breast Cancer Research : BCR|November 27, 2015
β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasionSarah J Creed, Caroline P Le, Mona Hassan, et al.
Nature|October 15, 2013
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugsRon O Dror, Hillary F Green, Celine Valant, et al.
Molecular Systems Biology|May 12, 2025
The solute carrier superfamily interactomeFabian Frommelt, Rene Ladurner, Ulrich Goldmann, et al.
European Journal of Medicinal Chemistry|June 26, 2026
Dual-target mu opioid-dopamine D3 receptor (MOR-D3R) ligands based on etonitazene: New leads for transforming "nitazenes" into novel analgesicsKhorshada Jahan, Grant Glatfelter, Julie Sanchez, et al.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Frontiers in Pharmacology|July 25, 2024
Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamilyDaniela Digles, Alvaro Ingles-Prieto, Vojtech Dvorak, et al.
Science Signaling|April 3, 2020
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonistsAlexander Gillis, Arisbel B Gondin, Andrea Kliewer, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptorsStephen Ph Alexander, Arthur Christopoulos, Anthony P Davenport, et al.
Pageof 33